Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.

Category Primary study
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2010
The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection.
Epistemonikos ID: 6757d39acc611a06fa93f44d4c86f1d1337a188d
First added on: Sep 22, 2024